Trial · NCT01328093
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Double-Blind Phase | STARTED | LY2140023-DB / LY2140023-OL | 516 | |
| Double-Blind Phase | STARTED | Aripiprazole-DB / LY2140023-OL | 162 | |
| Double-Blind Phase | Received at Least 1 Dose of Study Drug | LY2140023-DB / LY2140023-OL | 514 | |
| Double-Blind Phase | Received at Least 1 Dose of Study Drug | Aripiprazole-DB / LY2140023-OL | 161 | |
| Double-Blind Phase | Modified Intent-To-Treat (mITT) | LY2140023-DB / LY2140023-OL | 511 | |
| Double-Blind Phase | Modified Intent-To-Treat (mITT) | Aripiprazole-DB / LY2140023-OL | 161 | |
| Double-Blind Phase | COMPLETED | LY2140023-DB / LY2140023-OL | 231 | |
| Double-Blind Phase | COMPLETED | Aripiprazole-DB / LY2140023-OL | 84 | |
| Double-Blind Phase | NOT COMPLETED | LY2140023-DB / LY2140023-OL | 285 | |
| Double-Blind Phase | NOT COMPLETED | Aripiprazole-DB / LY2140023-OL | 78 | |
| Open-Label Phase | STARTED | LY2140023-DB / LY2140023-OL | 200 | |
| Open-Label Phase | STARTED | Aripiprazole-DB / LY2140023-OL | 73 | |
| Open-Label Phase | Received at Least 1 Dose of Study Drug | LY2140023-DB / LY2140023-OL | 198 | |
| Open-Label Phase | Received at Least 1 Dose of Study Drug | Aripiprazole-DB / LY2140023-OL | 73 | |
| Open-Label Phase | Modified Intent-To-Treat (mITT) | LY2140023-DB / LY2140023-OL | 197 | |
| Open-Label Phase | Modified Intent-To-Treat (mITT) | Aripiprazole-DB / LY2140023-OL | 73 | |
| Open-Label Phase | COMPLETED | LY2140023-DB / LY2140023-OL | 60 | |
| Open-Label Phase | COMPLETED | Aripiprazole-DB / LY2140023-OL | 23 | |
| Open-Label Phase | NOT COMPLETED | LY2140023-DB / LY2140023-OL | 140 | |
| Open-Label Phase | NOT COMPLETED | Aripiprazole-DB / LY2140023-OL | 50 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01328093/flow